Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 128 | 589 | 42 | 313 | 26 |
| Cost of Goods | 60 | 265 | 11 | 8 | 2 |
| Gross Profit | 68 | 324 | 32 | 305 | 24 |
| Operating Expenses | 2,035 | 3,722 | 3,758 | 2,360 | 6,244 |
| Operating Income | -1,906 | -3,133 | -3,716 | -2,047 | -6,219 |
| Interest Expense | 57 | 135 | 127 | 15 | 18 |
| Other Income | 66 | -271 | 70 | 32 | 62 |
| Pre-tax Income | -1,897 | -3,538 | -3,772 | -2,030 | -6,175 |
| Income Tax | N/A | 963 | 4 | -83 | -87 |
| Net Income Continuous | -1,897 | -4,501 | -3,777 | -1,947 | -6,088 |
| Minority Interests | -74 | 363 | -72 | -88 | -92 |
| Net Income | $-1,824 | $-4,864 | $-3,705 | $-1,859 | $-5,995 |
| EPS Basic Total Ops | -0.55 | -1.46 | -1.14 | -0.59 | -2.00 |
| EPS Basic Continuous Ops | -0.57 | -1.32 | -1.16 | -0.62 | -2.05 |
| EPS Diluted Total Ops | -0.55 | -1.46 | -1.14 | -0.59 | -2.00 |
| EPS Diluted Continuous Ops | -0.57 | -1.32 | -1.16 | -0.62 | -2.05 |
| EBITDA(a) | $-1,900 | $-3,127 | $-3,709 | $-2,041 | $-6,213 |